Michael Osterholm

Prof. Michael Osterholm discusses bird flu in US dairy cows, its potential to spread to humans, and the risks of consumption. Insights on virus evolution, cross-species transmission, outbreak detection challenges, and precautions for the public. Emphasis on pandemic preparedness and surveillance in farm animals.

Join infectious disease expert Michael Osterholm and vaccine researcher Ted Ross as they delve into the NIH's ambitious plan for a universal vaccine. They discuss the potential of a single shot for flu and COVID-19 that could last for years. The conversation covers the challenges of vaccine development, addressing public hesitancy, and the innovative COBRA program that uses AI in vaccine design. With clinical trials on the horizon, they explore the complexities of ensuring trust and efficacy in public health strategies.

Michael Osterholm, an infectious disease expert from the University of Minnesota, joins health politics reporter Dan Diamond and vaccine specialist Dr. Haley Gans from Stanford. They dive into the troubling low vaccination rates as flu season approaches, discussing the critical need for community efforts. The guests explore the increasing vaccine hesitancy influenced by mixed messages around COVID-19 and potential health policies under the incoming Trump administration, raising concerns over misinformation and public health risks.

Dr. Michael Osterholm, a renowned expert in infectious disease epidemiology, dives into the complexities of the COVID-19 pandemic. He discusses the impact of misinformation and highlights how COVID-19 variants, especially in wildlife, complicate management efforts. Osterholm explores the origins of SARS-CoV, emphasizing the need for transparency in research. He also examines long COVID, health disparities tied to vitamin D, and the role of barbershops in community health education. The conversation underscores the importance of humility in public health communication.

Michael Osterholm, Director of the Center for Infectious Disease Research and Policy at the University of Minnesota, shares invaluable insights on COVID-19. He discusses the true case fatality rate and how factors like obesity influence outcomes. Michael highlights the importance of immunity and cautions about supply chain issues affecting vaccines and testing. He also reflects on future protection strategies for healthcare workers and the long-term health implications for COVID survivors. His perspective balances optimism with the challenges still ahead.